Cogent Biosciences, Inc.
US ˙ NasdaqGS ˙ US19240Q2012

SecurityCOGT / Cogent Biosciences, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,714,927 shares
Latest Disclosed Value $ 66,007,540
Citadel Advisors Llc ownership in COGT / Cogent Biosciences, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,714,927 shares of Cogent Biosciences, Inc. (US:COGT) valued at $66,007,540 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,438,994 shares of Cogent Biosciences, Inc.. This represents a change in shares of 19.18% during the quarter. The current value of the position is $53,197,036 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (COGT) in the form of stock options. The firm currently holds call options representing 101,600 of underlying shares valued at $3,910,584 USD and put options representing 90,900 of underlying shares valued at $3,498,741 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

COGT / Cogent Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F COGENT BIOSCIENCES COM 19240Q201 1,714,927 275,933 19.18 66,008 29.14 0.0094
2026-02-17 2025-12-31 13F COGENT BIOSCIENCES COM 19240Q201 1,438,994 -228,813 -13.72 51,113 113.42 0.0068
2025-11-14 2025-09-30 13F COGENT BIOSCIENCES COM 19240Q201 1,667,807 1,046,572 168.47 23,950 436.97 0.0036
2025-08-14 2025-06-30 13F COGENT BIOSCIENCES COM 19240Q201 621,235 131,547 26.86 4,460 52.06 0.0008
2025-05-15 2025-03-31 13F COGENT BIOSCIENCES COM 19240Q201 489,688 392,025 401.41 2,933 285.41 0.0006
2025-02-14 2024-12-31 13F COGENT BIOSCIENCES COM 19240Q201 97,663 88,016 912.37 762 631.73 0.0001
2024-11-14 2024-09-30 13F COGENT BIOSCIENCES COM 19240Q201 9,647 603 6.67 104 36.84 0.0000
2024-08-14 2024-06-30 13F COGENT BIOSCIENCES COM 19240Q201 9,044 -122,847 -93.14 76 -91.42 0.0000
2024-05-15 2024-03-31 13F COGENT BIOSCIENCES COM 19240Q201 131,891 -508,880 -79.42 886 -76.48 0.0002
2024-02-14 2023-12-31 13F COGENT BIOSCIENCES COM 19240Q201 640,771 580,166 957.29 3,768 538.47 0.0008
2023-11-14 2023-09-30 13F COGENT BIOSCIENCES COM 19240Q201 60,605 -74,162 -55.03 591 -63.01 0.0001
2023-08-14 2023-06-30 13F COGENT BIOSCIENCES COM 19240Q201 134,767 -1,161,005 -89.60 1,596 -88.59 0.0003
2023-05-15 2023-03-31 13F COGENT BIOSCIENCES COM 19240Q201 1,295,772 -558,548 -30.12 13,981 -34.77 0.0031
2023-02-14 2022-12-31 13F COGENT BIOSCIENCES COM 19240Q201 1,854,320 522,040 39.18 21,436 7.83 0.0050
2022-11-14 2022-09-30 13F COGENT BIOSCIENCES COM 19240Q201 1,332,280 260,766 24.34 19,878 105.67 0.0045
2022-08-15 2022-06-30 13F COGENT BIOSCIENCES COM 19240Q201 1,071,514 1,006,013 1,535.87 9,665 1,868.43 0.0025
2022-05-16 2022-03-31 13F COGENT BIOSCIENCES COM 19240Q201 65,501 65,501 491 0.0001
2022-02-14 2021-12-31 13F COGENT BIOSCIENCES Cmn 19240Q201 0 -14,340 -100.00 0 -100.00
2021-11-15 2021-09-30 13F COGENT BIOSCIENCES Cmn 19240Q201 14,340 14,340 121 0.0000
2021-08-16 2021-06-30 13F UNUM THERAPEUTICS COM 19240Q201 0 -1,303,659 -100.00 0 -100.00
2021-05-21 2021-03-31 13F/A-1 UNUM THERAPEUTICS COM 19240Q201 1,303,659 446,717 52.13 11,136 15.72 0.0027
2021-05-17 2021-03-31 13F UNUM THERAPEUTICS COM 19240Q201 1,303,659 446,717 11,136 0.0027
2021-02-16 2020-12-31 13F COGENT BIOSCIENCES COM 19240Q201 856,942 831,937 3,327.08 9,623 16,210.17 0.0025
2020-11-16 2020-09-30 13F UNUM THERAPEUTICS COM 903214104 25,005 9,001 56.24 59 742.86 0.0000
2020-08-14 2020-06-30 13F UNUM THERAPEUTICS Cmn 903214104 16,004 -3,309 -17.13 7 -12.50 0.0000
2020-05-15 2020-03-31 13F UNUM THERAPEUTICS Cmn 903214104 19,313 19,313 8 0.0000
2019-08-14 2019-06-30 13F UNUM THERAPEUTICS Cmn 903214104 0 -20,728 -100.00 0 -100.00
2019-05-15 2019-03-31 13F UNUM THERAPEUTICS Cmn 903214104 20,728 20,728 91 0.0000
2019-02-14 2018-12-31 13F UNUM THERAPEUTICS Cmn 903214104 0 -22,794 -100.00 0 -100.00
2018-11-13 2018-09-30 13F UNUM THERAPEUTICS Cmn 903214104 22,794 22,794 235 0.0001
2018-08-14 2018-06-30 13F/A-1 UNUM THERAPEUTICS Cmn 903214104 0 -37,400 -100.00 0 -100.00
2018-05-14 2018-03-31 13F/A-1 UNUM THERAPEUTICS Cmn 903214104 37,400 37,400 416 0.0002
2018-05-11 2018-03-31 13F UNUM THERAPEUTICS Cmn 903214104 37,400 416 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F COGENT BIOSCIENCES COM Call 101,600 38.99 3,911 50.62 n/a n/a n/a
2026-02-17 2025-12-31 13F COGENT BIOSCIENCES COM Call 73,100 504.13 2,597 1,400.58 n/a n/a n/a
2025-11-14 2025-09-30 13F COGENT BIOSCIENCES COM Call 12,100 -75.99 174 -52.08 n/a n/a n/a
2025-08-14 2025-06-30 13F COGENT BIOSCIENCES COM Call 50,400 500.00 362 622.00 n/a n/a n/a
2025-05-15 2025-03-31 13F COGENT BIOSCIENCES COM Call 8,400 -79.16 50 -84.08 n/a n/a n/a
2025-02-14 2024-12-31 13F COGENT BIOSCIENCES COM Call 40,300 5.50 314 -23.79 n/a n/a n/a
2024-11-14 2024-09-30 13F COGENT BIOSCIENCES COM Call 38,200 4.37 413 33.77 n/a n/a n/a
2024-08-14 2024-06-30 13F COGENT BIOSCIENCES COM Call 36,600 31.65 309 65.59 n/a n/a n/a
2024-05-15 2024-03-31 13F COGENT BIOSCIENCES COM Call 27,800 -40.22 187 -31.87 n/a n/a n/a
2024-02-14 2023-12-31 13F COGENT BIOSCIENCES COM Call 46,500 133.67 273 40.72 n/a n/a n/a
2023-11-14 2023-09-30 13F COGENT BIOSCIENCES COM Call 19,900 25.16 194 3.19 n/a n/a n/a
2023-08-14 2023-06-30 13F COGENT BIOSCIENCES COM Call 15,900 22.31 188 34.29 n/a n/a n/a
2023-05-15 2023-03-31 13F COGENT BIOSCIENCES COM Call 13,000 -64.77 140 -67.14 n/a n/a n/a
2023-02-14 2022-12-31 13F COGENT BIOSCIENCES COM Call 36,900 -23.12 427 -40.50 n/a n/a n/a
2022-11-14 2022-09-30 13F COGENT BIOSCIENCES COM Call 48,000 -18.23 716 35.35 n/a n/a n/a
2022-08-15 2022-06-30 13F COGENT BIOSCIENCES COM Call 58,700 529 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F COGENT BIOSCIENCES COM Put 90,900 14.63 3,499 24.22 n/a n/a n/a
2026-02-17 2025-12-31 13F COGENT BIOSCIENCES COM Put 79,300 260.45 2,817 793.97 n/a n/a n/a
2025-11-14 2025-09-30 13F COGENT BIOSCIENCES COM Put 22,000 -58.02 316 -16.22 n/a n/a n/a
2025-08-14 2025-06-30 13F COGENT BIOSCIENCES COM Put 52,400 164.65 376 218.64 n/a n/a n/a
2025-05-15 2025-03-31 13F COGENT BIOSCIENCES COM Put 19,800 -6.16 119 -28.05 n/a n/a n/a
2025-02-14 2024-12-31 13F COGENT BIOSCIENCES COM Put 21,100 -15.26 165 -38.81 n/a n/a n/a
2024-11-14 2024-09-30 13F COGENT BIOSCIENCES COM Put 24,900 -23.15 269 -1.83 n/a n/a n/a
2024-08-14 2024-06-30 13F COGENT BIOSCIENCES COM Put 32,400 101.24 273 152.78 n/a n/a n/a
2024-05-15 2024-03-31 13F COGENT BIOSCIENCES COM Put 16,100 292.68 108 350.00 n/a n/a n/a
2024-02-14 2023-12-31 13F COGENT BIOSCIENCES COM Put 4,100 -18.00 24 -50.00 n/a n/a n/a
2023-11-14 2023-09-30 13F COGENT BIOSCIENCES COM Put 5,000 455.56 49 380.00 n/a n/a n/a
2023-08-14 2023-06-30 13F COGENT BIOSCIENCES COM Put 900 -78.57 11 -77.78 n/a n/a n/a
2023-05-15 2023-03-31 13F COGENT BIOSCIENCES COM Put 4,200 250.00 45 246.15 n/a n/a n/a
2023-02-14 2022-12-31 13F COGENT BIOSCIENCES COM Put 1,200 -94.03 14 -95.67 n/a n/a n/a
2022-11-14 2022-09-30 13F COGENT BIOSCIENCES COM Put 20,100 -0.50 300 64.84 n/a n/a n/a
2022-08-15 2022-06-30 13F COGENT BIOSCIENCES COM Put 20,200 182 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.